Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOTECH Share Issue/Capital Change 2017

Feb 6, 2017

9301_rns_2017-02-06_53d7e8a3-cdfa-494e-9ab4-db67081f364e.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

The Biotech Growth Trust Plc - Blocklisting - Interim Review

PR Newswire

London, February 6

BLOCK LISTING SIX MONTHLY RETURN

Legal Entity Identifier 549300Z41EP32MI2DN29

Date: 6 February 2017

Name of applicant: The Biotech Growth Trust PLC
Name of scheme: General
Period of return: From: 5 August 2016 To: 5 February 2017
Balance of unallotted securities under scheme(s) from previous return: 6,058,134
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): Nil
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): Nil
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 6,058,134
Name of contact: Mark Pope – Frostrow Capital LLP
Telephone number of contact: 020 3008 4913